Skip to main content

FDA scientists appear to offer major endorsement of aducanumab, Biogen's controversial Alzheimer's treatment

By Stat News  
   November 04, 2020

The future of aducanumab, Biogen’s treatment for Alzheimer’s disease, appears brighter after reviewers at the Food and Drug Administration indicated they believed the drug was sufficiently safe and effective.

Full story

Get the latest on healthcare leadership in your inbox.